Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Manhattan Bridge Capital Inc is a reit-mortgage business based in the US. Manhattan Bridge Capital shares (LOAN) are listed on the NASDAQ and all prices are listed in US Dollars. Manhattan Bridge Capital employs 5 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$6.11|
|52-week range||$3.81 - $7.75|
|50-day moving average||$6.56|
|200-day moving average||$6.50|
|Wall St. target price||$7.00|
|Dividend yield||$0.47 (7.61%)|
|Earnings per share (TTM)||$0.42|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-1.77%|
|1 month (2021-09-24)||-11.83%|
|3 months (2021-07-23)||-2.86%|
|6 months (2021-04-23)||-0.49%|
|1 year (2020-10-23)||45.13%|
|2 years (2019-10-24)||-1.13%|
|3 years (2018-10-24)||0.83%|
|5 years (2016-10-24)||6.325|
Valuing Manhattan Bridge Capital stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Manhattan Bridge Capital's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Manhattan Bridge Capital's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Manhattan Bridge Capital shares trade at around 15x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
|Revenue TTM||$5.7 million|
|Operating margin TTM||74.33%|
|Gross profit TTM||$5.7 million|
|Return on assets TTM||7.43%|
|Return on equity TTM||10.85%|
|Market capitalisation||$70.2 million|
TTM: trailing 12 months
There are currently 42,853 Manhattan Bridge Capital shares held short by investors – that's known as Manhattan Bridge Capital's "short interest". This figure is 394.8% up from 8,660 last month.
There are a few different ways that this level of interest in shorting Manhattan Bridge Capital shares can be evaluated.
Manhattan Bridge Capital's "short interest ratio" (SIR) is the quantity of Manhattan Bridge Capital shares currently shorted divided by the average quantity of Manhattan Bridge Capital shares traded daily (recently around 45108.421052632). Manhattan Bridge Capital's SIR currently stands at 0.95. In other words for every 100,000 Manhattan Bridge Capital shares traded daily on the market, roughly 950 shares are currently held short.
However Manhattan Bridge Capital's short interest can also be evaluated against the total number of Manhattan Bridge Capital shares, or, against the total number of tradable Manhattan Bridge Capital shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Manhattan Bridge Capital's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Manhattan Bridge Capital shares in existence, roughly 0 shares are currently held short) or 0.0049% of the tradable shares (for every 100,000 tradable Manhattan Bridge Capital shares, roughly 5 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Manhattan Bridge Capital.
Find out more about how you can short Manhattan Bridge Capital stock.
Dividend payout ratio: 85.45% of net profits
Recently Manhattan Bridge Capital has paid out, on average, around 85.45% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 8.19% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Manhattan Bridge Capital shareholders could enjoy a 8.19% return on their shares, in the form of dividend payments. In Manhattan Bridge Capital's case, that would currently equate to about $0.47 per share.
Manhattan Bridge Capital's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Manhattan Bridge Capital's most recent dividend payout was on 14 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 6 October 2021 (the "ex-dividend date").
Over the last 12 months, Manhattan Bridge Capital's shares have ranged in value from as little as $3.812 up to $7.7467. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Manhattan Bridge Capital's is 0.6661. This would suggest that Manhattan Bridge Capital's shares are less volatile than average (for this exchange).
Manhattan Bridge Capital, Inc. , a real estate finance company, originates, services, and manages a portfolio of first mortgage loans in the United States. It offers short-term, secured, and non-banking loans to real estate investors to fund their acquisition, renovation, rehabilitation, or enhancement of properties in the New York metropolitan area, including New Jersey and Connecticut, and in Florida. The company's loans are primarily secured by collateral consisting of real estate and accompanied by personal guarantees from the principals of the borrowers. It qualifies as a real estate investment trust for federal income tax purposes. The company generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Manhattan Bridge Capital, Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.